WESTBOROUGH, Mass.--(BUSINESS WIRE)--PharmaVigilant announces that ParinGenix Inc. has decided to migrate their existing trials previously conducted in paper, into PharmaVigilant’s I –Warehouse. All of ParinGenix’s trials will now be integrated into one data warehouse, along with the InSpire Reporting Tool. This will enable ParinGenix to access and analyze their data either within one trial, or across trials. “We chose PharmaVigilant’s solution because it allowed us to have all of our data in one place. It provided flexible access to our data whenever we want, to do the queries we want, and to receive the data immediately. It helps us to make informed decisions quickly, within a study and across studies”, said Dr. Teresa Arledge, Chief Development Officer for ParinGenix. “Having access to all of my data and up-to-the-minute status of study conduct available to me wherever and whenever I need it, allows me to efficiently manage my program.”